Epstein Secrets

nding the largest round of funding yet to a CRISPR-Cas9 startup. Cambridge-based Editas Medicine is announcing a $120 million Series B round led by Bill Gates's chief advisor for science and technology, Boris Nikolic. The list of financiers teaming with Nikolic reads like a rolodex of so-called crossover in

s, Jennison Associates, Khosla Ventures, EcoR1 Capital, Casdin Capital, Omega Funds, Cowen Private Investments, and Alexandria Venture Investments. Editas' founding VC backers—Flagship Ventures Polaris Partners and Third Rock Ventures-also pitched in, as did Partners Innovation Fund. Nikolic, who is j

0, 2019 Ex-Bill Gates adviser `shocked' to be named one of Jeffrey Epstein's executors NY Post By Lia Eustachewich 8/20/19 Jeffrey Epstein named Bill Gates' former science adviser as one of three executors of his $578 million estate — though the man said he was "shocked" to learn of the news. Boris Nikol

xcited about financial advice that Epstein, a former hedge-fund manager who was obsessed with genetic research, shared with private bankers ahead of Editas' public offering, the source told Bloomberg. Nikolic was part of a broad network that overlapped with Epstein, Nikolic's spokeswoman said. A rep fo

false." Ex-Bill Gates adviser 'shocked' to be named one of Jeffrey Epstein's executors NY Post By Lia Eustachewich 8/20/19 Jeffrey Epstein named Bill Gates' former science adviser as one of three executors of his $578 million estate — though the man said he was "shocked" to learn of the news. Boris Nikol

xcited about financial advice that Epstein, a former hedge-fund manager who was obsessed with genetic research, shared with private bankers ahead of Editas' public offering, the source told Bloomberg. Nikolic was part of a broad network that overlapped with Epstein, Nikolic's spokeswoman said. A rep fo